KRAS and neoplasm: As well as disease stage, tumor genotype could also be an important determinant of culture success in these conditions: previous studies focus on biopsies and plural effusions from EGFR‐mutant/ALK‐positive tumors, while 7 of our 10 LUAD tumors were driven by mutant KRAS.